Autoregulation of blood flow, endothelial nitric oxide synthase and microvascular rarefaction.
Prewitt
Russell L
RL
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001160:Arterioles / Q000033:anatomy & histology / Q000187:drug effects / Q000201:enzymology; D001794:Blood Pressure / Q000502:physiology*; D002196:Capillaries / Q000033:anatomy & histology / Q000187:drug effects / Q000201:enzymology; D006706:Homeostasis / Q000502:physiology*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000201:enzymology; D008833:Microcirculation / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000098:blood supply / Q000187:drug effects / Q000201:enzymology; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III; D014655:Vascular Resistance / Q000187:drug effects
D000959:Antihypertensive Agents; D006830:Hydralazine; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III